Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase Ia clinical trial to assess the safety and immunogenicity of MVA-EBO Z alone and a heterologous prime-boost immunisation with ChAd3-EBO Z and MVA-EBO Z in healthy UK volunteers

Next Previous
Trial Profile

A Phase Ia clinical trial to assess the safety and immunogenicity of MVA-EBO Z alone and a heterologous prime-boost immunisation with ChAd3-EBO Z and MVA-EBO Z in healthy UK volunteers

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 04 Jul 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs GSK 3390107A (Primary) ; MVA EBOZ vaccine Emergent BioSolutions (Primary)
  • Indications Ebola virus infections
  • Focus Adverse reactions

    • Most Recent Events

    • 08 Nov 2018 Results published in the Journal of Infectious Diseases
    • 10 Dec 2015 Planned End Date changed from 1 Dec 2015 to 22 Oct 2015 according to United Kingdom Clinical Research Network.
    • 10 Dec 2015 Status changed from recruiting to active, no longer recruiting according to United Kingdom Clinical Research Network.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top